Campbell Newman Asset Management’s Elevance Health ELV Stock Holding History

Campbell Newman Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-67,384	Closed	-$8.85M	–	108
2016 Q2	$8.85M	Sell	67,384 -7,600	-10%	-$1.04M	1.61%	28
2016 Q1	$10.4M	Buy	74,984 +3,636	+5%	+$486K	2.17%	24
2015 Q4	$9.95M	Buy	71,348 +875	+1%	+$121K	2.17%	22
2015 Q3	$9.87M	Sell	70,473 -6,008	-8%	-$903K	2.24%	22
2015 Q2	$12.6M	Sell	76,481 -5,920	-7%	-$946K	2.49%	22
2015 Q1	$12.7M	Buy	+82,401	New	+$11.7M	2.34%	22

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Campbell Newman Asset Management's ELV Position: Q3 2016 in Review

Campbell Newman Asset Management sold out of Elevance Health (ELV) in Q3 2016, closing a stake of 67,384 shares — an estimated $8.85M sold.

Campbell Newman Asset Management first reported a position in ELV in Q1 2015 and held it in 6 quarters. The position peaked at $12.7M in Q1 2015. 737 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

Campbell Newman Asset Management reported no remaining Elevance Health position as of Q3 2016 after selling out during the quarter.
Campbell Newman Asset Management sold 67,384 Elevance Health shares in Q3 2016, an estimated $8.85M.
Campbell Newman Asset Management first reported a position in Elevance Health in Q1 2015 and held it in 6 quarters.
Campbell Newman Asset Management's Elevance Health position peaked at $12.7M in Q1 2015.
737 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Campbell Newman Asset Management's 13F filing for Q3 2016, filed 31 Oct 2016.